Home › Multiple Sclerosis › Ohio
Pag-aaral pangklinika para sa Multiple Sclerosis sa Ohio
15 pag-aaral para sa Multiple Sclerosis ang naghahanap ng mga kalahok sa mga site sa Ohio.
Mga Lungsod sa Ohio
Opisyal na teksto ng pag-aaral (English)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT03816345RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Cleveland Clinic, Cleveland
- The Ohio State University, Department of Psychiatry, Columbus
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT07002034Understanding and Enhancing Human Health and Movement
- Louis Stokes Cleveland VA Medical Center, Cleveland
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07738978A Phase 2a Study of SUN-627 in Participants With Non-Active Secondary Progressive and Primary Progressive Multiple Sclerosis (SPMS/PPMS)
- Local Institution - Site 104, Columbus
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT07840326A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Centerville
- TG Therapeutics Investigational Trial Site, Centerville
- TG Therapeutics Investigational Trial Site, Cincinnati
- at 4 pa
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06433752A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- University of Cincinnati Medical Center, Cincinnati
- Riverside Methodist Hospital, Columbus
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06782490A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Cleveland
- TG Therapeutics Investigational Trial Site, Columbus
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT06680037Care in Multiple Sclerosis (MS)
- Cleveland Clinic, Cleveland
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 29 · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT07011914Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- The Ohio State University- Site Number : 8400009, Columbus
- The Boster Center for Multiple Sclerosis- Site Number : 8400006, Columbus
Nagre-recruitPhase 3
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07325292A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Cleveland Clinic Ohio, Cleveland
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT07225504Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
- University of Cincinnati, Cincinnati
Nagre-recruitPhase 1/2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Set 21, 2026 · NCT07477639An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
- Research Site, Cleveland
Nagre-recruitPhase 1
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT07224373Electrical Stimulation Exercise for Individuals With Lower Limb Paralysis
- Louis Stokes Cleveland VA Medical Center, Cleveland
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 17, 2026 · NCT07768761Central Vein Sign in Multiple Sclerosis Extension Study
- Cleveland Clinic Foundation, Cleveland
Nagre-recruit
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Peb 20, 2026 · NCT07424027Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
- Cleveland State University, Cleveland
Nagre-recruit
Edad 22 hanggang 75 · Lahat ng kasarian · Na-update Set 24, 2025 · NCT05964829Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.